Aligos Therapeutics, Inc.
ALGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$32 | -$16 | $43 | -$82 |
| Dep. & Amort. | $0 | $0 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $1 | $2 |
| Change in WC | $2 | $1 | -$4 | -$0 |
| Other Non-Cash | $5 | -$2 | -$62 | $62 |
| Operating Cash Flow | -$24 | -$16 | -$21 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$22 | -$39 | -$64 | $0 |
| Inv. Sales/Matur. | $70 | $0 | $20 | $20 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $48 | -$39 | -$44 | $20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | $0 | -$0 |
| Stock Issued | -$0 | -$0 | $102 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$0 | -$0 | $102 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $23 | -$55 | $37 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19 | $74 | $37 | $35 |
| End Cash | $42 | $19 | $74 | $37 |
| Free Cash Flow | -$25 | -$16 | -$21 | -$18 |